SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
SanBio Total Assets (Quarterly): 34.25M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 34.25M |
| October 31, 2023 | 28.86M |
| July 31, 2023 | 34.63M |
| April 30, 2023 | 43.52M |
| January 31, 2023 | 53.98M |
| October 31, 2022 | 38.90M |
| July 31, 2022 | 64.54M |
| April 30, 2022 | 61.99M |
| January 31, 2022 | 47.81M |
| October 31, 2021 | 72.66M |
| July 31, 2021 | 88.48M |
| April 30, 2021 | 105.78M |
| January 31, 2021 | 127.45M |
| October 31, 2020 | 131.05M |
| July 31, 2020 | 131.79M |
| April 30, 2020 | 132.96M |
| January 31, 2020 | 143.27M |
| October 31, 2019 | 158.21M |
| July 31, 2019 | 168.87M |
| Date | Value |
|---|---|
| April 30, 2019 | 115.39M |
| January 31, 2019 | 128.22M |
| October 31, 2018 | 123.33M |
| July 31, 2018 | 133.24M |
| April 30, 2018 | 73.43M |
| January 31, 2018 | 47.76M |
| October 31, 2017 | 43.32M |
| July 31, 2017 | 48.75M |
| April 30, 2017 | 57.53M |
| January 31, 2017 | 55.35M |
| October 31, 2016 | 65.27M |
| July 31, 2016 | 64.03M |
| April 30, 2016 | 70.87M |
| January 31, 2016 | 69.56M |
| October 31, 2015 | 72.58M |
| July 31, 2015 | 71.62M |
| April 30, 2015 | 76.40M |
| January 31, 2015 | 14.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.86M
Minimum
Oct 2023
168.87M
Maximum
Jul 2019
87.84M
Average
72.66M
Median
Oct 2021
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 99.82B |
| Nxera Pharma Co Ltd | 1.006B |
| PeptiDream Inc | 460.09M |
| Healios KK | 108.91M |
| AnGes Inc | 185.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.30M |
| Shareholders Equity (Quarterly) | 18.95M |